U.S. FDA

FDA Officials Wrestle with CBD in Day-Long Meeting on Science “Challenges”

The FDA still has more questions than answers on CBD, but it is making strides on conducting the research and collecting the data needed to release product regulations.

Regulation
Hemp

Hemp Policy Item Tabled Amid Concerns at Meeting of U.S. Ag Regulators

Citing concerns about hemp used as cover for higher-THC cannabis, a NASDA policy committee tabled a proposal to lift some requirements for industrial hemp.

Newsletter

FDA nabs new cannabis advisor • Canopy divests from retail in Canada • Illinois’ cautionary tale on equity

An excerpt from recent editions of the Cannabis Wire Daily newsletter.